Ustekirel 45 mg Solution For Injection 0.5 ml

Ustekirel 45 mg Solution For Injection 0.5 ml belongs to a class of monoclonal antibody drugs. It treats various inflammatory conditions, including Crohn's disease and active ulcerative colitis, in adults 18 years and older. It can treat moderate to severe psoriasis and psoriatic arthritis in adults and children six years and older. Crohn's disease is a chronic inflammatory disorder that affects the digestive tract. It is a kind of inflammatory bowel disease (IBD). Psoriasis is a skin disease that causes an itchy, scaly rash on the knees, elbows, trunk, and scalp. Crohn's disease is a chronic inflammatory disorder that affects the digestive tract. It's a form of inflammatory bowel illness.

Ustekirel 45 mg Solution For Injection 0.5 ml contains Ustekinumab, a monoclonal antibody that targets and neutralises specific proteins (interleukin-12 and interleukin-23) in the body that contribute to inflammation and immune responses.

Ustekirel 45 mg Solution For Injection 0.5 ml will be administered by a healthcare professional; do not self-administer. Sometimes, you may experience nasal congestion, runny nose, sore throat, fever, headache, tiredness, itching, nausea and vomiting, diarrhoea, stomach pain, joint pain and redness at the injection site. Most of these side effects of Ustekirel 45 mg Solution For Injection 0.5 ml do not require medical attention and gradually resolve over time. However, if the side effects persist or worsen, please consult your doctor.

Before taking the Ustekirel 45 mg Solution For Injection 0.5 ml, let your doctor know about all your medical conditions, sensitivities, and medications you are using. Also, inform your doctor if you are pregnant or breastfeeding. Ustekirel 45 mg Solution For Injection 0.5 ml may have an impact on your immune system. Ustekirel 45 mg Solution For Injection 0.5 ml can raise your risk of significant adverse effects. Ustekirel 45 mg Solution For Injection 0.5 ml may impair your ability to fight infections and put you at risk. Some patients get significant infections while taking Ustekirel 45 mg Solution For Injection 0.5 ml, such as tuberculosis (TB) and infections caused by bacteria, fungi, or viruses, which may necessitate hospitalization. It is strongly advised that you be tested for tuberculosis before beginning Ustekirel 45 mg Solution For Injection 0.5 ml treatment and that you be regularly monitored for signs and symptoms of tuberculosis while on Ustekirel 45 mg Solution For Injection 0.5 ml. If your doctor believes you are at risk for tuberculosis, you may be treated for it before and throughout your Ustekirel 45 mg Solution For Injection 0.5 ml treatment.

Ustekirel 45 mg Solution For Injection 0.5 ml contains Ustekinumab, a monoclonal antibody that targets and neutralises specific proteins (interleukin-12 and interleukin-23) in the body that contribute to inflammation and immune responses. Thus, it helps to treat Crohn’s disease and active ulcerative colitis in adults 18 years and older. It can treat moderate to severe psoriasis and psoriatic arthritis in adults and children six years and older.

Ustekirel 45 mg Solution For Injection 0.5 ml may suppress your immune system and raise your chance of some cancers and infections, so notify your doctor if you have any infections (bacterial/fungal/protozoal/viral), malignancies or cancers. Also, tell your doctor if you have tuberculosis or PRES (Posterior Reversible Encephalopathy Syndrome) or have ever had an adverse response to Ustekinumab or any of the components in this medicine. Ustekirel 45 mg Solution For Injection 0.5 ml may cause significant allergic responses in some cases. If you experience any of the following symptoms of a major allergic reaction: feeling faint, swelling of your face, eyelids, tongue, or throat, chest tightness, or skin rash, get medical attention immediately.